Type to search

Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer | Pharmtech Focus
Dunad Therapeutics Enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies | Pharmtech Focus